EZH2 and glioblastoma: EZH2-dependent epigenetic silencing of the BMP receptor 1B (BMPR1B) in a subset of glioblastoma tumour-initiating cells (TICs) has also been noted, thereby limiting the extent to which the TICs can respond to differentiation signals (Lee et al., 2008).